Form 4: Hims & Hers Health CFO Oluyemi Okupe Sells Shares Under 10b5-1 Trading Plan

Hims & Hers Health CFO Oluyemi Okupe sold shares of Class A Common Stock on December 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On December 20, 2024, Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., sold shares of Class A Common Stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 31, 2024.
• A total of 19,000 shares were sold in multiple transactions at prices ranging from $25.64 to $25.955.
• Following the reported transactions, Okupe directly owns 132,578 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sentiment is neutral as it simply reports transactions without expressing any opinion on the company's performance or future prospects.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned through Rule 10b5-1 trading plans to avoid accusations of trading on inside information. The market typically views such sales in the context of the overall financial health and prospects of the company.

Comparison to Industry Standards

• Comparing insider trading activity to similar companies in the telehealth and pharmaceutical sectors can provide context.
• For example, Teladoc Health and GoodRx have also seen insider trading activity, with the frequency and size of transactions varying based on individual circumstances and company performance.
• Benchmarking against these companies involves analyzing the ratio of insider sales to total shares outstanding and the timing of these transactions relative to earnings announcements or other significant corporate events.

Stakeholder Impact

• The stock sale could have a minor impact on shareholder sentiment, depending on how the market interprets the transaction.
• The sale does not directly impact employees, customers, suppliers, or creditors.

Key Dates